Davignon, Jean
McGill University · Université de Montréal
19 papers on CoChatORCID 0000-0002-8365-6552
Most cited papers
- Verified
Role of Endothelial Dysfunction in Atherosclerosis
Davignon, J., & Ganz, P. (2004) · Circulation
Nitric Oxide and Endothelin EffectsCardiovascular Health and Disease Prevention
Cited by 2,513
- Verified
Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis: The ASTEROID Trial
Nissen, S. E., Nicholls, S. J., Sipahi, I., Libby, P., Raichlen, J. S., Ballantyne, C. M., Davignon, J., Erbel, R., Fruchart, J. C., Tardif, J.-C., et al. (2006) · JAMA
Lipoproteins and Cardiovascular HealthCoronary Interventions and Diagnostics
Cited by 2,047
- Verified
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
Lipoproteins and Cardiovascular HealthLipid metabolism and disorders
Cited by 1,981
- Verified
Beneficial Cardiovascular Pleiotropic Effects of Statins
Davignon, J. (2004) · Circulation
Lipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular Diseases
Cited by 955
- Verified · note
Proprotein convertase subtilisin/kexin type 9 (PCSK9): Hepatocyte‐specific low‐density lipoprotein receptor degradation and critical role in mouse liver regeneration†
Zaid, A., Roubtsova, A., Essalmani, R., Marcinkiewicz, J., Chamberland, A., Hamelin, J., Tremblay, M., Jacques, H., Jin, W., Davignon, J., et al. (2008) · Hepatology
Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism
Cited by 404
- Verified
Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity.
Cohn, J. S., Patterson, B. W., Uffelman, K. D., Davignon, J., & Steiner, G. (2004) · The Journal of Clinical Endocrinology & Metabolism
Lipid metabolism and disordersDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 170
- Verified
Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins
Cohn, J. S., Marcoux, C., & Davignon, J. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 156
- Verified
Apolipoprotein E and β-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent
Beffert, U., Cohn, J. S., Petit-Turcotte, C., Tremblay, M., Aumont, N., Ramassamy, C., Davignon, J., & Poirier, J. (1999) · Brain Research
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 142
- Verified
Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.
Batal, R., Tremblay, M., Barrett, P. H. R., Jacques, H., Fredenrich, A., Mamer, O., Davignon, J., & Cohn, J. S. (2000) · Journal of Lipid Research
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 113
- Verified
Novel loss-of-function PCSK9 variant is associated with low plasma LDL cholesterol in a French-Canadian family and with impaired processing and secretion in cell culture
Mayne, J., Dewpura, T., Raymond, A., Bernier, L., Cousins, M., Ooi, T. C., Davignon, J., Seidah, N. G., Mbikay, M., & Chrétien, M. (2011) · Clinical Chemistry
Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism
Cited by 111
- Verified
Egg yolk consumption and carotid plaque
Spence, J. D., Jenkins, D. J. A., & Davignon, J. (2012) · Atherosclerosis
Lipoproteins and Cardiovascular HealthNutritional Studies and Diet
Cited by 85
- Verified
Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients
Marcoux, C., Tremblay, M., Nakajima, K., Davignon, J., & Cohn, J. S. (1999) · Journal of Lipid Research
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 61
- Verified
Characterization of human plasma apolipoprotein E-containing lipoproteins in the high density lipoprotein size range: focus on pre-beta1-LpE, pre-beta2-LpE, and alpha-LpE
Krimbou, L., Tremblay, M., Davignon, J., & Cohn, J. S. (1997) · Journal of Lipid Research
Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular Health
Cited by 53
- Verified
Remnant-like particle cholesterol and triglyceride levels of hypertriglyceridemic patients in the fed and fasted state.
Marcoux, C., Hopkins, P. N., Wang, T., Leary, E. T., Nakajima, K., Davignon, J., & Cohn, J. S. (2000) · Journal of Lipid Research
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 43
- Verified
Plasma kinetics of VLDL and HDL apoC-I in normolipidemic and hypertriglyceridemic subjects
Cohn, J. S., Tremblay, M., Batal, R., Jacques, H., Veilleux, L., Rodriguez, C., Bernier, L., Mamer, O., & Davignon, J. (2002) · Journal of Lipid Research
Lipid metabolism and disordersCholesterol and Lipid Metabolism
Cited by 41
- Verified
Characterization of a new apolipoprotein E5 variant detected in two French-Canadian subjects
Mailly, F., Xu, C., Xhignesse, M., Lussier-Cacan, S., Talmud, P., Davignon, J., Humphries, S., & Nestruck, A. (1991) · Journal of Lipid Research
Lipoproteins and Cardiovascular HealthLipid metabolism and disorders
Cited by 36
- Verified
Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans
Cohn, J. S., Batal, R., Tremblay, M., Jacques, H., Veilleux, L., Rodriguez, C., Mamer, O., & Davignon, J. (2003) · Journal of Lipid Research
Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular Health
Cited by 35
- Verified
Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia
Cohn, J. S., Tremblay, M., Batal, R., Jacques, H., Veilleux, L., Rodriguez, C., Barrett, P. H. R., Dubreuil, D., Roy, M., Bernier, L., et al. (2002) · Journal of Lipid Research
Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism
Cited by 27
- Verified
Identification and characterization of a novel apolipoprotein E variant, apolipoprotein E3' (Arg136–>His): association with mild dyslipidemia and double pre-beta very low density lipoproteins
Minnich, A., Weisgraber, K. H., Newhouse, Y., Dong, L. M., Fortin, L. J., Tremblay, M., & Davignon, J. (1995) · Journal of Lipid Research
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 26
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free